Results 281 to 290 of about 127,027 (324)
Some of the next articles are maybe not open access.
Thrombosis and Haemostasis, 1966
Summary1. Intraocular fibrinolysis can be induced in rabbits by intravenous administration of streptokinase and plasminogen. Enhancement of intraocular fibrinolysis, however, requires a substantial increase in the fibrinolytic activity of the blood. Hence any attempt to induce therapeutic intraocular fibrinolysis by injection of fibrinolytic enzymes ...
Inga Marie Nilsson +2 more
openaire +3 more sources
Summary1. Intraocular fibrinolysis can be induced in rabbits by intravenous administration of streptokinase and plasminogen. Enhancement of intraocular fibrinolysis, however, requires a substantial increase in the fibrinolytic activity of the blood. Hence any attempt to induce therapeutic intraocular fibrinolysis by injection of fibrinolytic enzymes ...
Inga Marie Nilsson +2 more
openaire +3 more sources
Fibrin and Fibrinolysis in Cancer
Seminars in Thrombosis and Hemostasis, 2019In 1878, Billroth discovered that tumor cells invest themselves in a fibrin thrombus, and he hypothesized that fibrin promotes tumor growth and invasion.
H. Kwaan, P. Lindholm
semanticscholar +1 more source
Chest, 1992
Fibrinolytic therapy has an expanding role in the treatment of many thromboembolic disorders. Four fibrinolytic drugs are currently marketed: streptokinase, anisoylated plasminogen-streptokinase activator complex, urokinase, and recombinant human tissue-type plasminogen activator.
openaire +3 more sources
Fibrinolytic therapy has an expanding role in the treatment of many thromboembolic disorders. Four fibrinolytic drugs are currently marketed: streptokinase, anisoylated plasminogen-streptokinase activator complex, urokinase, and recombinant human tissue-type plasminogen activator.
openaire +3 more sources
Acta Haematologica, 1972
The fibrinolytic system has been studied in 12 patients with myelomatosis. Ten had some impairment of their fibrinolytic mechanisms and 4 of these had laboratory evidence of intravascular coagulation. Defective fibrinolysis may be an important factor in the pathogenesis of thromboembolicphenomena in myelomatosis.
D. Lee, F.E. Preston
openaire +3 more sources
The fibrinolytic system has been studied in 12 patients with myelomatosis. Ten had some impairment of their fibrinolytic mechanisms and 4 of these had laboratory evidence of intravascular coagulation. Defective fibrinolysis may be an important factor in the pathogenesis of thromboembolicphenomena in myelomatosis.
D. Lee, F.E. Preston
openaire +3 more sources
Australian and New Zealand Journal of Medicine, 1972
Summary: Platelet function has been examined in humans during periods of enhanced fibrinolysis induced by streptokinase or occurring spontaneously. The degree of lytic activity has been assessed by thrombin times, fibrinogen levels and measurement of fibrin degradation pro-ducts in the serum.
P. A. Castaldi, J. J. Gorman
openaire +3 more sources
Summary: Platelet function has been examined in humans during periods of enhanced fibrinolysis induced by streptokinase or occurring spontaneously. The degree of lytic activity has been assessed by thrombin times, fibrinogen levels and measurement of fibrin degradation pro-ducts in the serum.
P. A. Castaldi, J. J. Gorman
openaire +3 more sources
Thrombosis and Haemostasis, 1972
SummaryFibrinolytic activity is described in the bile of man and of several species of mammal. This activity can be precipitated from whole bile by ammonium sulphate, by acetone, and by a chlor of orm/methanol partition technique. It behaves as an anion at pH 7.4.
openaire +3 more sources
SummaryFibrinolytic activity is described in the bile of man and of several species of mammal. This activity can be precipitated from whole bile by ammonium sulphate, by acetone, and by a chlor of orm/methanol partition technique. It behaves as an anion at pH 7.4.
openaire +3 more sources
The Macrophage and Fibrinolysis [PDF]
Seminars in Thrombosis and Hemostasis, 1996 The monocyte/macrophage plays a central role in fibrinolysis. Cell-surface of components of the plasminogen activator system leads to the elaboration of plasmin, which facilitates degradation of fibrin in the pericellular environment, as well as activation of matrixins, which promote degradation of matrix components.
openaire +2 more sources
Acta Paediatrica, 1970
SummaryThe fibrinolytic system was studied in 207 normal fullterm newborns during the first 5 days of life. A high, but rapidly decreasing plasminogen activator activity was found during the first 4 hours in umbilical vein blood in all of the children studied.
H. Ekelund +2 more
openaire +3 more sources
SummaryThe fibrinolytic system was studied in 207 normal fullterm newborns during the first 5 days of life. A high, but rapidly decreasing plasminogen activator activity was found during the first 4 hours in umbilical vein blood in all of the children studied.
H. Ekelund +2 more
openaire +3 more sources
Best Practice & Research Clinical Haematology, 1999
The fibrinolytic system generates plasmin, which dissolves fibrin in haemostatic plugs and in thrombi. It is often regarded simply as a secondary phenomenon responsive to the generation of thrombi but it is, rather, in dynamic balance with fibrin formation, such that abnormalities in either can lead to thrombosis.
openaire +3 more sources
The fibrinolytic system generates plasmin, which dissolves fibrin in haemostatic plugs and in thrombi. It is often regarded simply as a secondary phenomenon responsive to the generation of thrombi but it is, rather, in dynamic balance with fibrin formation, such that abnormalities in either can lead to thrombosis.
openaire +3 more sources
Thrombosis Research, 1976
Abstract Many patients receiving Adriamycin (Doxorubicin hydrochloride) were noted to manifest painful subungual hemorrhages which resolved after cessation of therapy. In addition, many Adriamycin patients were noted to demonstrate elevated levels of fibrinogen/fibrin degradation products when evaluated for unrelated hemostatic defects. An evaluation
Lajos F. Fekete +2 more
openaire +3 more sources
Abstract Many patients receiving Adriamycin (Doxorubicin hydrochloride) were noted to manifest painful subungual hemorrhages which resolved after cessation of therapy. In addition, many Adriamycin patients were noted to demonstrate elevated levels of fibrinogen/fibrin degradation products when evaluated for unrelated hemostatic defects. An evaluation
Lajos F. Fekete +2 more
openaire +3 more sources